280 Park Ave,32nd Floor
NEW YORK , NY, 10017
NEW YORK , NY, 10017
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in components of the Unde More
Webiste
Directors
Jun 14, 2023- Matthew Stroyman
- Patrick P. Campo
- Jonathan Krane
- John Ferguson
Chief Compliance Officer
- Michael Quain
Price
- $ 19.34 ( -0.3 )
-
Oct 17, 2023Last Close
- Net Assets
-
$1.9M
Nov 29, 2023
- 52-Week High/Low
- $0 - $0
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-68.02%
5 Year
-12.85%
Best
378.75%
2020
Worst
-73.98%
2021
Company Name |
Holding |
International Holding Company P.J.S.C | 5.03 % |
SAMSUNG BIOLOGICS CO.,LTD. | 4.25 % |
Bangkok Dusit Medical Services Public Company Limited | 4.24 % |
Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.18 % |
IHH HEALTHCARE BERHAD | 3.99 % |
Celltrion, Inc. | 3.98 % |
Rede D\'Or Sao Luiz S.A. | 3.67 % |
Celltrion Healthcare Co Ltd | 2.85 % |
WUXI BIOLOGICS (CAYMAN) INC. | 2.63 % |
Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 2.39 % |
More | 2.39 % |
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KMED | 0% | 0% | -11.7% | -21.3% | -74% | 378.8% | 9.8% | -64.6% | 7.5% | 35% | |
S&P 500 | 6.8% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 0% | -4.2% | -12% | -27.6% | -6.7% | 9.9% | 0% | 0% | 0% | ||||
q2 | 0% | 0% | -1.8% | -7.6% | -2.2% | 35.2% | -7.8% | 0% | 0% | 0% | ||||
q3 | 0% | 0% | -5.8% | -12.6% | -12.8% | 109.6% | -5.4% | 2% | 0% | 0% | ||||
q4 | 0% | 0% | 0.3% | 10.6% | -3% | 81% | 10.4% | -17.6% | 0% | 0% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |